Literature DB >> 20421111

Multifactorial comparison of modified and conventional perfusion strategies in a porcine model of cardiopulmonary bypass.

Bader E Hussaini1, Patrick R Treanor, Nancy A Healey, Xiu-Gui Lu, Shukri F Khuri, Hemant S Thatte.   

Abstract

BACKGROUND: Utilization of thromboresistant circuits in cardiopulmonary bypass (CPB) surgery has been controversial. However, due to the advantages associated with these types of circuits, we sought to evaluate the efficacy of use of low-dose heparin in conjunction with thromboresistant surfaces, closed perfusion system, elimination of blood-gas interface, maintenance of hematocrit to >25%, and systemic normothermia, with respect to the conventional strategy of non-thromboresistant open circuits with high-dose heparin, during 3 h of CPB in an animal model.
METHODS: Using an open-chest swine model, animals were placed on CPB for 3 h with additional monitoring for 1 h post-CPB. Pigs were randomized into either a heparin-bonded circuit (HBC) group (n = 10) or a non-HBC (NHB) group (n = 10). Hemodynamic, hematologic, and biochemical parameters and multiphoton microscopy were used to compare the two groups.
RESULTS: Pigs in the HBC group showed a 38.4% reduction in post-CPB blood loss in comparison with the NHB group (P = 0.0007). Additionally, compared with the HBC group, the NHB group exhibited a 32.7% post-CPB reduction in platelets (P < 0.001) and significant increases in alkaline phosphatase, aspartate aminotransferase, and creatine phosphokinase enzymes (P < 0.0202, P = 0.0015, P < 0.0001; respectively). Multiphoton imaging of the arterial filters revealed no entrapment of RBC, WBC, and platelets in the HBC group, while the filters in the NHB group were clogged by these cells.
CONCLUSION: Utilization of modified perfusion strategy employing low-dose heparin and closed thromboresistant circuits is successful in ameliorating the potential adverse hematologic and pro-inflammatory elements induced with open perfusion system of non-thromboresistant circuits most commonly used in cardiac surgery. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20421111     DOI: 10.1016/j.jss.2010.01.037

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  2 in total

1.  Thromboresistant cardiopulmonary bypass circuits: room for improvement?

Authors:  Jeffrey A Poynter
Journal:  J Surg Res       Date:  2010-03-19       Impact factor: 2.192

2.  Blood management issues: getting clots together when you want them.

Authors:  Darryl McMillan; Kieron Potger; Joanne Southwell
Journal:  J Extra Corpor Technol       Date:  2011-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.